Epirubicin and docetaxel is an effective neoadjuvant therapy for breast cancer: Result of a phase II study

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Jun 2006
Event	American Society of Clinical Oncology (ASCO) Annual Meeting - Duration: Jan 1 2014 → …

Conference	American Society of Clinical Oncology (ASCO) Annual Meeting
Period	1/1/14 → …

Disciplines

@conference{8f82943d7c854cb6af2f8301b5d38866,

title = "Epirubicin and docetaxel is an effective neoadjuvant therapy for breast cancer: Result of a phase II study",

author = "Venkatappa, \{Siddhartha A\}",

year = "2006",

month = jun,

language = "American English",

note = "American Society of Clinical Oncology (ASCO) Annual Meeting ; Conference date: 01-01-2014",

}